washingtonpost.com
States have responded to the slow rollout of coronavirus vaccine by expanding eligibility for the shots to people over 65. But the moves have made it more difficult to recruit and retain test subjects for clinical trials of vaccines that have yet to win emergency authorization.
about 3 years ago
washingtonpost.com
Senior administration officials have stressed the importance of redundancy in
vaccine supply to prepare for the possible need to administer booster shots
against mutated variants, as well as the potential of shots for children under
16 early next year.
almost 3 years ago
washingtonpost.com
Johnson & Johnson has grappled with vaccine manufacturing delays associated with production at the Emergent plant in Baltimore.
almost 3 years ago
washingtonpost.com
Industry fights over global vaccine patents are just warming up - The Washington Post
over 2 years ago
washingtonpost.com
The House Oversight select subcommittee on the coronavirus crisis is investigating events at Emergent BioSolutions that led to a vaccine production shutdown that is now in its fifth week.
over 2 years ago
washingtonpost.com
Emergent BioSolutions says the FDA allowed it to restart production after a
lengthy suspension, an interim step toward winning full manufacturing
authorization of Johnson & Johnson coronavirus vaccine.
over 2 years ago
washingtonpost.com
As the threat of the delta variant grows, nursing home chains also are beginning to adopt vaccine mandates, including the largest nonprofit and for-profit chains.
over 2 years ago
Search by beat, location, outlet & position to find the right journalists for your story.
Sign up for freewashingtonpost.com
A 10-year legal saga over inflated Medicare billings at a Florida-based nursing
home chain is likely to end with only a small payment for U.S. taxpayers.
over 2 years ago
washingtonpost.com
Pfizer-BioNTech led its U.S. rivals in 2021 manufacturing, but ultracold freezer requirements make its vaccine harder to ship to remote parts of the world.
about 2 years ago
washingtonpost.com
Companies face a big test in 2022 as they tweak vaccines, dosages and boosters to meet the threat of coronavirus mutations.
about 2 years ago
washingtonpost.com
Patients are confronted with denials by both private insurance companies and the
Social Security Administration as they fight for disability benefits for the
debilitating symptoms of long covid. Many are forced to retain lawyers and may
end up in federal court.
almost 2 years ago
